David L. Johnson
David L. Johnson was one of the original organizers and serves today as President of BioCrossroads, a market-based enterprise seeking to improve Indiana's economic future through investments and jobs in the region’s substantial life sciences sector. Among its many activities, BioCrossroads informs and educates; raises and invests venture capital funds in promising new companies; and builds business collaborations by bridging gaps across academia and industry. Through his work at BioCrossroads, Johnson has been responsible for raising over a quarter-billion dollars in philanthropic and venture capital funding for efforts and investments to advance new companies, promote innovative research, and deliver on the promise of highly skilled 21st-Century employment opportunities for Hoosiers.
A longtime business leader and lawyer, Johnson is an honors graduate of Harvard College, Harvard Law School and Oxford University, where he studied as a Rhodes Scholar.
Nora Doherty joined BioCrossroads in 2003 after working many years with entrepreneurial companies. She is vice president of finance for BioCrossroads and managing director for its Seed Funds. In this role, she serves on the Board of Directors of portfolio companies including FAST, SonarMed, and Grest among others. Doherty also supports other program-related activities.
Doherty has a history of working for entrepreneurial companies. She was vice president of Electronic Evolutions and a co-founder, vice president of Operations and vice president Legal, Human Resources and Administration, and corporate secretary with Escient Technologies. Escient Technologies managed numerous consumer electronic and internet related businesses, including Gracenote® which was purchased by Sony in 2008.
Doherty received her BA and MBA from Indiana University, where she was a member of the honors program. She also received the "Excellence in Leadership" award as special recognition from the professors and administration of Indiana University MBA-CIP for leadership and contribution to the program.
Troy Hege serves as Project Director for BioCrossroads working to vet and develop emergent life science opportunities. Hege directly supports several BioCrossroads initiatives including the Indiana Health Information Exchange (IHIE) and the Fairbanks Institute for Health Communities and also works closely with the Indiana Clinical Translational Sciences Institute. Hege also serves as an advisor to the Indiana Enterprise Fund and Indiana Seed Fund II and assists the fund manager in deal sourcing, diligence and execution of portfolio investments.
In addition, Hege serves on the boards of directors for the Indy Hub, an organization formed with the support of BioCrossroads to advance the brand and vitality of the city of Indianapolis for young professionals, and the Datalys Center, a BioCrossroads supported sports medicine research institute formed in collaboration with the National Collegiate Athletic Association and the American College of Sports Medicine.
Prior to joining BioCrossroads, Hege spent seven years in management consulting, including two years at The Edison Group, a healthcare management consultancy he founded. Hege also has worked for consulting firms in Boston and New York, where he advised leading healthcare, pharmaceutical and technology companies in brand management, business development and technology strategy. Hege received his BS degree from Purdue University and MBA from Harvard Business School.
Brian Stemme serves as Project Director for BioCrossroads, working to identify and develop collaborations between Indiana's research universities, government and private sector. Stemme manages BioCrossroadsLINX, an initiative focused on leveraging Indiana’s strengths in pharmaceutical development and manufacturing supports the state’s economic development efforts in the life science industry. In addition, he assesses early-stage companies for the Indiana Seed Fund II and sits on the boards of Aarden Pharmaceuticals, AgeneBio, and Muroplex Therapeutics.
Before joining BioCrossroads, Stemme worked in corporate affairs and financial roles for Eli Lilly and Company and Arthur Andersen. He earned a BS in Accounting from Butler University in Indianapolis and has served as president of its alumni association.
Lori LeRoy serves as Public Relations and Marketing Director for BioCrossroads and leads their public/media relations activities as well as their internal and external communications strategies. She also directs advertising and general marketing activities.
LeRoy was previously marketing manager, communications for Roche Diagnostics Diabetes Care business area. She was also a public relations consultant at Roche where she managed product public relations for its laboratory, hospital, physician’s office and research products. With a strong background in consumer PR, brand awareness campaigns and health care/technology PR, she has also held positions as senior manager, corporate communications at Philips Consumer Electronics and corporate communications manager at AirTran Airways.
She earned a B.A. in English and Asian Studies from Oglethorpe University in Atlanta, where she also served as a member of the Alumni Association Board of Directors.
Matt Hall is Director of Projects and Finance for BioCrossroads. He joined the BioCrossroads team in 2007 to work on project development, capital formation and enterprise investment of BioCrossroads, its entities and initiatives. In that role, Hall serves as an advisor to the Indiana Enterprise Fund and Indiana Seed Fund II, assisting the manager in deal sourcing, diligence and execution of portfolio investments. Hall served as the project lead on BioCrossroads’ strategic analysis of Indiana’s orthopedic industry that led to the successful organization, funding and launch of OrthoWorx; a stand-alone enterprise supporting Indiana’s orthopedic cluster. Hall continues to support OrthoWorx on key projects and leads BioCrossroads’ ongoing orthopedic engagement efforts with university and industry stakeholders.
Hall is a member of the OrthoWorx Strategic Advisory Board, OrthoWorx Audit Committee, OrthoWorx Compensation Committee, the Indiana University Public Policy Institute’s State and Local Tax Commission and the Woodrow Wilson Indiana Teaching Fellowship Foundation Advisory Council. He has also served on the Indiana University Medical Group Foundation Investment Committee, the Indianapolis Charter Schools Board and several local community development boards.
A graduate of Indiana University, Hall has a strong background in structured finance, investment banking and economic development. Prior to joining BioCrossroads he was Vice President – Investment Banking, Public Sector Finance for NatCity Investments, where he managed the operations of the firm’s public debt securities practice in Indiana, Illinois, Kentucky and Missouri. Prior to that role, Hall advised the City of Indianapolis on municipal finance, economic and real estate development projects.
Julie Routt is BioCrossroads’ office manager and executive assistant to the vice president of finance. Julie has been with BioCrossroads since 2003. Prior to joining the organization, Julie worked at the Indy Partnership, the Indianapolis Mayor’s Office, and the Indianapolis Zoo. She is a graduate of Tri-State University in Angola, Indiana.
Brenda Bratton joined BioCrossroads in January 2005 as Executive Assistant for David Johnson, President and CEO. Previously she worked at the law firm of Baker & Daniels for 15 years.